We are live on
!
Find out more
KFS
Kelly Financial Services Portfolio holdings
AUM
$467M
1-Year Est. Return
21.13%
This Fund
S&P 500
This Quarter
Est. Return
-0.55%
1 Year Est. Return
+21.13%
3 Year Est. Return
+58.45%
5 Year Est. Return
+59.78%
10 Year Est. Return
–
AUM
$178M
AUM Growth
-$2.41B
(-93%)
Cap. Flow
-$28.6B
Cap. Flow
% of AUM
-16,090.76%
Top 10 Holdings %
Top 10 Hldgs %
74.86%
Holding
671
New
32
Increased
1
Reduced
610
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$60.2K |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$49.7K |
| 3 |
Nektar Therapeutics
NKTR
|
+$48.1K |
| 4 |
INmune Bio
INMB
|
+$38.6K |
| 5 |
DT Midstream
DTM
|
+$25.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 2 |
iShares Expanded Tech Sector ETF
IGM
|
+$4.87B |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$2.08B |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.86B |
| 5 |
iShares Core Dividend Growth ETF
DGRO
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.92% |
| 2 | Materials | 2.24% |
| 3 | Healthcare | 1.73% |
| 4 | Financials | 1.46% |
| 5 | Industrials | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTOO
551
DELISTED
T2 Biosystems, Inc
TTOO
| – | – |
0
| – | – |
|
552
Karyopharm Therapeutics
KPTI
$48M
| $1.46K | ﹤0.01% |
17
-155
| -90% | -$16.1K |
|
553
Clearway Energy Class C
CWEN
$6.7B
| $1.42K | ﹤0.01% |
47
-1,181
| -96% | -$35.2K |
|
554
Kroger
KR
$34.8B
| $1.42K | ﹤0.01% |
35
-1,306
| -97% | -$54.8K |
|
555
Halliburton
HAL
$26.6B
| $1.39K | ﹤0.01% |
64
-1,421
| -96% | -$29.1K |
|
556
Teva Pharmaceuticals
TEVA
$41.2B
| $1.36K | ﹤0.01% |
140
-1,246
| -90% | -$11.7K |
|
|
CWEN.A
557
DELISTED
Clearway Energy Class A
CWEN.A
| $1.34K | ﹤0.01% |
48
-1,137
| -96% | -$32K |
|
558
Ferrari
RACE
$72.5B
| $1.25K | ﹤0.01% |
6
-1,230
| -100% | -$264K |
|
559
Kontoor Brands
KTB
$4.26B
| $1.24K | ﹤0.01% |
25
-1,372
| -98% | -$76K |
|
560
Hexcel
HXL
$7.82B
| $1.22K | ﹤0.01% |
21
-1,262
| -98% | -$72.8K |
|
561
Ribbon Communications
RBBN
$383M
| $1.2K | ﹤0.01% |
200
-1,322
| -87% | -$8.93K |
|
|
TELL
562
DELISTED
Tellurian Inc.
TELL
| $1.17K | ﹤0.01% |
300
-1,095
| -78% | -$3.74K |
|
563
Ventas
VTR
$47.9B
| $1.14K | ﹤0.01% |
21
-1,153
| -98% | -$66.1K |
|
|
VIVS
564
VivoSim Labs
VIVS
$1.64M
| $1.14K | ﹤0.01% |
14
-118
| -89% | -$10.8K |
|
565
Occidental Petroleum
OXY
$55.9B
| $1.09K | ﹤0.01% |
37
-1,120
| -97% | -$29.9K |
|
566
Unilever
UL
$136B
| $1.08K | ﹤0.01% |
18
-1,012
| -98% | -$64.5K |
|
567
Gilead Sciences
GILD
$165B
| $1.04K | ﹤0.01% |
15
-1,150
| -99% | -$80.8K |
|
568
Acushnet Holdings
GOLF
$5.45B
| $1.04K | ﹤0.01% |
22
-1,073
| -98% | -$54.5K |
|
569
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
| $1.02K | ﹤0.01% |
57
-3,045
| -98% | -$55.9K |
|
570
Baxter International
BAX
$14.2B
| $1.01K | ﹤0.01% |
13
-995
| -99% | -$78.6K |
|
571
Ionis Pharmaceuticals
IONS
$9.4B
| $1.01K | ﹤0.01% |
30
-1,167
| -97% | -$44K |
|
|
ITRM
572
DELISTED
Iterum Therapeutics
ITRM
| $1K | ﹤0.01% |
120
-157
| -57% | -$1.93K |
|
|
SCHR
573
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $935 | ﹤0.01% |
32
-1,840
| -98% | -$52.6K |
|
574
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.59B
| $845 | ﹤0.01% |
19
-823
| -98% | -$38.2K |
|
575
PharmaCyte Biotech
PMCB
$6.34M
| $831 | ﹤0.01% |
+262
| New | +$921 |
|
Similar funds
PC
VCM
SP
HP
JHC
UC
LN
SCA
Kelly Financial Services's Q3 2021 Portfolio in Review
As of Q3 2021, Kelly Financial Services held 671 positions worth $178M, down 93% from $2.58B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Kelly Financial Services withdrew a net $28.6B in Q3 2021, closing 25 positions and reducing 610 holdings. Its most notable exit was Manulife Financial, an estimated $3.76M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, up from 1.9% a quarter earlier, followed by Materials and Healthcare.
Against the trend, Kelly Financial Services opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $60.2K.
- Kelly Financial Services's largest Q3 2021 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 658 shares worth $60.2K.
- Kelly Financial Services added most to Zomedica Corp. in Q3 2021, an estimated $148 increase.
- Kelly Financial Services's biggest Q3 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $7.48B.
- Kelly Financial Services fully exited Manulife Financial in Q3 2021, selling an estimated $3.76M.
- Kelly Financial Services's ten largest holdings make up 75% of its $178M portfolio in Q3 2021.
- Kelly Financial Services opened 32 new positions and closed 25 in Q3 2021.
- Kelly Financial Services's portfolio value fell 93% quarter-over-quarter to $178M.
Based on Kelly Financial Services's 13F filing for Q3 2021, filed 17 Jul 2024.